Abbreviations {#s0010}
=============

CoVcoronavirusMERS-CoVMiddle East respiratory syndrome coronavirusSARS-CoVsevere acute respiratory syndrome coronavirusIBVinfectious bronchitis virus

Introduction {#s0015}
============

The Coronaviridae have a global distribution. Most of the humans coronavirus (CoV) infectious have a serious effect. The Coronaviridae includes several animals and human viruses causing a serious epidemies and endemics, as such the severe acute respiratory syndrome (SARS) CoV (SARS-CoV) outbreak in 2003 and the CoV respiratory syndrome outbreak in 2012--14. Severe CoV acute respiratory virus (*SARS-CoV*) infection and the Middle East respiratory syndrome (MERS) CoV (*MERS-CoV*) in humans in 2012 caused severe lower respiratory tract disease as well as *IBV* (infectious bronchitis virus) in the avian and poultry field.

Emergent and Reemerging Viral Infections {#s0020}
========================================

An emerging infectious disease is defined as an infectious disease whose incidence has increased over the past 20 years and may increase in the future. Emerging infections account for more than 10% of human diseases ([@bib47]). An emerging pathogen may be defined as an infectious agent whose frequency or geographic range increases following its first introduction into a new host population, while a reemerging pathogen is one whose incidence or geographic distribution is increasing in an existing host population as a result of long-term changes in its underlying epidemiology. The emergence of pathogens may be based on subjective criteria, which may reflect increasing awareness, improved diagnosis, discovery of previously unrecognized infectious agents as well as any objective epidemiological data ([@bib95], [@bib27]).

Many viruses are classified as emerging pathogens according to the WHO, including *MERS-CoV*, *SARS-CoV*, and *IBV* that are the focus of this work.

Taxonomy {#s0025}
========

Phylogenetically, Coronaviridae belongs to Nidovirales in group IV, with a single genomic RNA fragment, oriented in a positive direction.

Nidovirales {#s0030}
-----------

Nidovirales is an order that contains four families (Arteriviridae, Coronaviridae, Mesoniviridae, and Roniviridae) according to the genomic classification ([Fig. 7.1](#f0010){ref-type="fig"} ) ([@bib8]). The name Nidovirales originates from the fact that the viruses belonging to this order have the capacity to produce during infection a 3′-multiplexed complex of subgenomic messenger RNA (mRNA), hence the word "nidus" in Latin, which means to nest ([@bib18]).Figure 7.1Nidovirales taxonomy ([@bib11]).

The main common traits between Nidovirales are as follows:•Their unfragmented genome of RNA type with positive orientation of the genome ([@bib8]).•Nidovirales encodes structural proteins that are separated from nonstructural functional proteins ([@bib4]).•The attachment to their host cell is done through receptors on the cell surface.•After which the fusion of the viral and cellular membrane is presumed to be mediated by one of the viral surface glycoproteins.

This fusion event (either plasma or endosomal membrane) releases the nucleocapsid into the cytoplasm of the host cell. Following genome takeoff, translation of two open replicase reading frames (ORFs) is initiated by ribosomes of the host, to produce large polyprotein precursors that undergo autoproteolysis to produce a replicase/transcriptase complex ([@bib33]).

Coronaviridae {#s0035}
-------------

The CoV family (Coronaviridae) has been described as a model in virology, because it infects more than 200 different hosts. SARS-CoV is compared to *Cinderella*. They were highlighted in 2003 ([@bib64]). CoVs are spherical (120--220 nm in diameter) and appear as special crowns because of the presence of pointed glycoproteins ([Fig. 7.2](#f0015){ref-type="fig"} ) ([@bib46]). Figure 7.2Structural scheme of the Nidovirales order.Despite the differences in structure observed at the members of this order, their genomic construction is similar as well as their replication strategies. They use to replicate a similar and distinct "nested set" transcription strategy, in which the expression of genes encoding structural viral proteins is mediated by a nested set of 3′-coterminal subgenomic mRNAs.*Source*: Reproduced with permission from King, A.M., Lefkowitz, E., Adams, M.J., Carstens, E.B. (Eds.), 2011. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier ([@bib40]). This figure has license from Elsevier under number 4285901264744.

CoVs are enveloped viruses that contain the largest linear genome of known positive-sense single-stranded viral RNA ([@bib68]). They are characterized by a structural organization of a crown around the envelope, hence their name Coronaviridae ([Fig. 7.4](#f0025){ref-type="fig"} ).Figure 7.4Phylogram of the Coronaviridae.*Source*: Reproduced with permission from Snijder, E.J., Bredenbeek, P.J., Dobbe, J.C., Thiel, V., Ziebuhr, J., Poon, L.L., et al., 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331 (5), 991--1004 ([@bib71]) with permission 4285910843400.

Although the first CoV, *IBV*, was discovered in 1932 ([@bib37]), Coronaviridae was proposed as a taxonomic family 30 years later after the discovery of human CoV in humans, patients with cold ([@bib78], [@bib79]).

In recent years, Coronaviridae have been considered among the most popular viral families because a number of its members were responsible for several human and animal epidemiological pathologies. These include the murine epidemic in 2005 ([@bib90]), the *SARS* in 2003 ([@bib30]), the SARS pandemic in 2015--16 in Russia and Ukraine ([@bib73]), the MERS-CoV 2012--17 ([@bib84]), and the CoV *IBV* ([@bib62]).

CoVs have diverse host ranges ([Fig. 7.3](#f0020){ref-type="fig"} ). They affect most terrestrial and marine animals and humans, including dolphins, birds, cattle, woodpeckers, fish, etc. It has been shown that a virus can infect various hosts, for example, SARS and MERS-CoV ([@bib87], [@bib77], [@bib5]).Figure 7.3Coronaviridae structural organization. Comparing the morphology in electron microscopy of coronaviruses whose prototype is the IBV virus and the Torovirinae *Torovirus*. *IBV*, Infectious bronchitis virus.*Source*: Reproduced with permission from Duckmanton L, Luan B, Devenish J, Tellier R, Petric M (1997). Characterization of torovirus from human faecal specimens. Virology 239: 158--168. Elsevier ([@bib23]). This figure has license from Elsevier under number 4285901264744.

The viral infection caused by this family is considered, in most cases, as a severe infection. It is mainly located in the respiratory and gastroenteric tracts by targeting routes according to the host and the infectious virus.

Coronaviridae include two subfamilies: Coronavirinae and Torovirinae. According to the molecular and serological characteristics of Coronavirinae, the classification reveals a subdivision into four groups (alpha coronavirus, beta coronavirus, delta coronavirus, and gamma coronavirus) and two genera in Torovirinae (*Bafinivirus*, *Torovirus*) ([@bib57], [@bib6]; Appendices 1 and 2) ([Fig. 7.4](#f0025){ref-type="fig"}).

Genomic Organization and Proteomics of Coronaviridae {#s0040}
====================================================

Coronaviridae is positive RNA viruses with an unsegmented genome of 26--33 kb in length. They are generally of similar genomic and structural construction, containing 5′-end ORF series that encode nonstructural proteins that are primarily involved in pathogenicity. The number of ORFs differs by species, and it has a significant portion of Coronaviridae genomes, followed by the coding regions of structural proteins, more than two-thirds of the CoV genome is composed of an open reading code (ORF) coding for the replicase polyprotein 1a/1b, and the remainder contains ORFs encoding the structural proteins: spicules (S), envelope (E), membrane (M), nucleoprotein (N), and a variable collection of accessory proteins ([@bib93], [@bib45]) ([Fig. 7.4](#f0025){ref-type="fig"}).

CoVs encode membrane-associated proteins that are incorporated into virions: spike (S), envelope (E), membrane (M), and nucleoprotein (N). These four proteins occur in the S--E--M--N order in all known CoV lineages ([@bib94]).

Among the spike envelope membrane and nucleoprotein (SEMN) genes, CoVs encode species-specific accessory proteins, many of which appear to be incorporated into virions at low levels, ranging from an accessory in alpha-CoVs, including human CoV NL63 ([@bib59]), to nine accessories provided in gamma- CoV HKU22 ([@bib94]). The genomic position of these accessory genes varies with S-encoded accessories in some beta-CoV, between S and E in most lineages, between M and N in most lineages, and after N rarely in alpha-CoVs and gamma-CoV and commonly in delta-CoVs. The M gene seems to follow the E gene directly through Coronaviridae, although there is no obvious transcriptional or transrational reason for which this should necessarily be the case ([Fig. 7.5](#f0030){ref-type="fig"} ).Figure 7.5Construction génomique des Coronaviridae.There is a similarity between human and animal coronaviruses at the organization level of their genome. All coronaviruses encode ORF replica 1a/1b and structural proteins (S), envelope (E), membrane (M), and nucleoprotein (N). In addition, each strain encodes several accessory proteins. Gene sizes are not designed for a specific scale.

Phylogenetic studies on RNA-dependent RNA polymerase (RdRp) sequences, aimed at studying divergence, suggested that the common ancestor, the most recent of the CoVs infecting mammals, appeared about 7000--8000 years ago, while the most recent common ancestor of avian CoVs dates back 10,000 years ([@bib82]). However, current estimates roughly coincide with the dispersion of the human population in the world from about 50,000--100,000 years ago and have increased significantly over the last 10,000 years during the first historical transition ([@bib10]). However, referring to the history of mankind, this epoch corresponds to the beginning of agriculture and animal husbandry.

*CoVs* are characterized by the property of transcribing code mRNAs for each protein. This property allows the virus to control the rate of protein synthesis according to the state requirements of virus and host cell.

Gene Responsible for Pathogenicity {#s0045}
----------------------------------

Protein S plays a key role in the power of pathogenicity. This glycoprotein (S) is an important component in the species specificity, pathogenesis, and escape of immunity. Like human immunodeficiency virus (HIV) gp160, influenza hemagglutinin, and Ebola virus glycoprotein, the CoV spike (S) glycoprotein protein is a class I viral fusion protein that mediates virus binding and fusion, allowing virus to enter the host cell ([@bib98]). Like other class I fusion proteins, the *S*-glycoprotein contains two functional domains, S1 and S2, linked by a protease cleavage site ([@bib98]). The S1 domain (17--756aa) contains the receptor-binding domain (RBD) (318--510aa) while the S2 region (757--1225aa) contains the two heptad repeat (HR) regions that facilitate viral fusion and a transmembrane domain (1189--1227aa) which anchors the tip on the viral envelope ([@bib98]). CoVs are thought to accumulate in cells by the following sequence of events: cell-receptor binding ACE2, DPP4, and APN to affect tropism in the cell by endocytosis and cleavage of SARS-CoV S by cathepsin-cell protease. L causes a rearrangement of S1 and S2 subunits inducing fusion of the viral membrane and the host to deposit the viral/nucleocapsid genome complex in the cytoplasm where replication occurs.

The glycoprotein of CoV S is an essential element of species specificity, which is also the main determinant of pathogenesis because a virus that is incapable of infection is unlikely to cause disease. Using reverse genetics, the substitution of mouse hepatitis virus (MHV) protein S for feline infectious peritonitis virus protein S alone was sufficient for the murine tropic virus to infect feline cells. In less extreme examples the host range of CoV can be modulated by a few point mutations in *S*-glycoprotein that focuses either in RBD or in the fusogenic domain ([@bib35]).

Although the earlier CoV dogma suggests that expansion of the host range is mediated by mutation in the S1 region, McRoy et al. reported an expansion of the host range of MHV that may also be mediated by changes in the host range, amino acids in fusion equipment of the S2 region. A prime and relevant example of a CoV host range change due to mutations in the S1 region was observed during the evolution of the SARS-CoV epidemic strain, SARS Urbani ([@bib35])

The SARS-CoV (S) peak gene sequences isolated from human cases during the early phase of the epidemic in 2002--03 and during the reemergence of 2003--04 are very similar to strain SZ16. SZ16 was isolated from palm tree crops in live animal markets in the Guangdong region of China during the outbreak, and its protein S differs from the epidemic strain, SARS Urbani, in 18 amino acids, 16 of which are in the S1 domain containing the RBD. The crystalline structure of ACE2-receptor-bound SARS-CoV RBD and biochemical experimentation demonstrated that the critical amino acids (K479, T487) in the SZ16 S civet RBD inhibited its binding to the human ACE2 receptor (hACE2), thereby providing a block in the expansion of host range and human pathogenesis ([@bib66]). Using a pseudotyped retrovirus with mutant or wild versions of the zoonotic (SZ16) or epidemic (Urbani) glycoprotein, Li et al. demonstrated that K479 and T487 were critical residues inhibiting the binding of the civet tip to the hACE2 receptor.

Unfortunately, the pseudotyped system is able to evaluate the efficiency of binding and entry, but not the growth kinetics of the virus. By using recombinant SARS-CoV carrying a variety of zoonotic, epidermal intermediate *S*-glycoproteins in a one-step growth pattern, data on binding, entry, and growth can be elucidated. In addition, infection of the cells expressing the civet (cACE2) or hACE2 of the SARS-CoV receptor with recombinant variants of SARS-CoV *S*-glycoproteins makes it possible to study the ability to grow and use receptors in both the amplifier and the epidemic host. In evaluating the growth of the SARS glycoprotein variant in CACE2 or hACE2 cell cultures, we deduced that the epidemic strain retained growth ability in cell cultures expressed by CACE2 and hACE2 ([@bib66]).

Viral Cycle of Coronaviridae {#s0050}
----------------------------

Here, we present the viral cycle of Coronaviridae by discussing the replication cycle of MERS-CoV as an example. The viral cycle of MERS-CoV is different from other beta-CoVs that do not code for hemagglutinin esterase ([@bib100]), ([Fig. 7.7](#f0045){ref-type="fig"} ).Figure 7.7Viral cycle of MERS coronavirus ([@bib24]). *MERS*, Middle East respiratory syndrome.

MERS-CoV binds to its DPP4 cellular receptor via the S protein, then it enters the target cells, followed by fusion of the endosomes and membranes of the virus resulting in the release of the genome of the viral RNA into the cytoplasm. The open reading frame (ORF), 1a and 1b, in the viral genomic RNA is translated into PP1a and PP1ab replicase polyproteins, respectively, and then optionally cleaved by a papain protease (PLpro), ([@bib99]) a type 3C cysteine protease (3CLpro, principle protease) and other viral proteinases, in 16 nonstructural proteins (nsp1--16) ([@bib24]).

A negative-stranded genomic length RNA is synthesized as a template for replication of viral genomic RNA. mRNAs of different lengths of the negative strand subgenome (sg mRNAs) are formed from the viral genome as discontinuous RNAs and used as a template to transcribe sg mRNAs. N viral protein is assembled with genomic RNA in the cytoplasm ([@bib102]).

The synthesized S, M, and E proteins are collected in the endoplasmic reticulum (ER) and transported to the ER-Golgi intermediate compartment where they interact with the N-RNA complex and assemble into viral particles. These become mature in the Golgi body and are released into cells ([@bib42]).

Middle East Respiratory Syndrome Coronavirus {#s0055}
============================================

The most infectious members of Coronaviridae belong to the beta group, particularly in lineage C where SARS and MERS-CoV are found to be highly pathogenic to humans and are responsible for severe epidemics worldwide, including the 2015--16 SARS pandemic in Russia, Ukraine ([@bib73]), and the current global epidemics of MERS according to the epidemiological history of this family ([Fig. 7.8](#f0050){ref-type="fig"} ).Figure 7.8Morphology of MERS-CoV particles as seen by negative-staining electron microscopy. Virions contain club-specific projections that originate from the viral membrane. Cynthia Goldsmith/Maureen Metcalfe/Azaibi Tamin (microscopic centers for disease control and prevention (CDC photo)). *MERS-CoV*, Middle East respiratory syndrome coronavirus.

Lack of vaccines or approved drugs is currently a roadblock to fight the epidemic and the spread of the disease ([@bib86]).

MERS-CoV is a pathogen that infects most mammals and higher animals, as well as humans. Camels represent CoV MERS nature reserves ([@bib3]). On the other hand, viruses are isolated from bats, and other mainly domestic animals such as mice, cattle, rats, etc. The infection is mainly due to the interaction with the DPP4 receptor for mammals and the ACE2 in bats. However, recently [@bib91] found that the DPP4 isolated from the intestinal and respiratory tissues from bats resembles those of camels and humans with an absence of DPP4 at the level of respiratory cells.

The CoV responsible for the MERS-CoV was first identified in Saudi Arabia in 2012 from a man with atypical pneumonia ([@bib100]). Since then, more than 1936 infections and more than 690 deaths have been reported ([@bib85]). The ongoing MERS-CoV epidemic is mainly concentrated in the Middle East and Saudi Arabia, but cases have been exported by travelers to over 27 countries causing occasional secondary spread ([@bib85]). In addition, the most notable epidemic outside of Saudi Arabia occurred in South Korea in 2015, resulting in 186 new cases ([@bib41]) ([Figure 7.6](#f0040){ref-type="fig"}, [Figure 7.7](#f0045){ref-type="fig"}, [Figure 7.8](#f0050){ref-type="fig"}, [Figure 7.9](#f0055){ref-type="fig"} ).Figure 7.6Mapping of interacting RNA domains with EPRS and RRS. (A) Mapping the region within F2 interacting with ERPS and RRS. F2 was divided into three fragments (F2.1, F2.2, and F2.3) which were used as baits in pulley tests, as well as F2 and F3 fragments or without (--) RNA as controls specificity. The presence of EPRS and RRS in the initial extract (I) and in the fractions drawn was analyzed by western blot. To simplify the information in [Fig. 7.6](#f0040){ref-type="fig"}, an empty channel has been removed in the EPRS panel, in which the dotted line indicates the splice site. Molecular weights in kDa of EPRS and RRS are shown on the left. (B) Identification of domain F2.2 in interaction with EPRS and RRS. F2.2 was divided into four fragments (F2.2L, F2.2R, F2.2U, and F2.2D), and their interactions with EPRS and RRS were analyzed by rapid analysis and western blot. The same experiment was performed with the F2.2 fragment or without (--) RNA as specificity controls. The molecular weights in EPRS and RRS kDa are shown on the left. (C) Sequential analysis of the F2.2L fragment. The bar on the top represents the TGEV genome, in which the different genes (ORF 1a, ORF 1b, S, 3a, 3b, E, M, N, and 7 genes), the leader sequence (L) and the 3′ UTRs are illustrated by boxes. The sequence alignment of the F2.2L viral fragment with the GAIT element of Cp GAIT and their respective secondary structures, in which residues A and U critical for the function of the element GAIT are described in green, are indicated. The numbers above the sequence alignment and in the secondary structure indicate the position of the F2.2L fragment genome. *Cp*, Ceruloplasmin; *UTR*, untranslated region.*Source*: Adopted after Marquez-Jurado, S., Nogales, A., Zuñiga, S., Enjuanes, L., Almazán, F., 2015. Identification of a gamma interferon-activated inhibitor of translation-like RNA motif at the 3′ end of the transmissible gastroenteritis Coronavirus genome modulating innate immune response. mBio 6 (2), e00105--e00115 ([@bib50]).Figure 7.9Spread of MERS-CoV worldwide ([@bib83]). *MERS-CoV*, Middle East respiratory syndrome coronavirus.Plus de 27 pays des cinq continents, et 2000 cas d'infection avec un ratio de mortalité de 39%. A noter ici, que ces statistiques concernent seulement l'Homme, alors que des études au niveau vétérinaire ont démontré la présence et la circulation du virus dans plusieurs pays chez des animaux domestiques.

The Genomic and Proteomic Construction {#s0060}
--------------------------------------

MERS-CoV is an enveloped virus, with a spherical coronary structure, and a nonsegmented, positively oriented, single-stranded RNA genome with a size of the order of 30 kb. ([Fig. 7.4](#f0025){ref-type="fig"}). It is related to strains hCoV-OC43 and hCoV-229E being prototype meadows and IBV being a prototype of all Coronaviridae ([@bib10]).

GuanineCystosine content (GC) represents 41% of the genome of MERS-CoV ([@bib80]). The genome is capped at the 5′ end and 3′ polyadenylated. At the 5′ end of MERS-CoV as in all Coronaviridae, there is an untranslated region (5′-UTR) of about 200 nucleotides (nts) before the initiation codon for the ORF.

ORF1 is translated by nonstructural proteins, a second ORF2 exists after the S gene and before the E gene codes for 3 nonstructural proteins which are 3a, 3b, 3c, and 3d. The structural genes are, respectively, spicule (S), envelope (E), membrane (M), and nucleocapsid (N). The MERS virus has the distinction of being more conserved in all hosts and citing humans with the exception of the mutation at position 1020 at the level of the gene coding for S which characterizes the strains infecting humans [@bib15].

The ORF1a products have proteolytic roles, interactions with interferon antagonist as well as DeiSGylation; however, ORF1b codes for RdRp and Helicase (Hel), which are important enzymes involved in the transcription and replication of CoVs. This is the result of cleavage of the polyprotein, ORF product a/b, by the papain-like protein cysteine protease (PLpro) and the protein 3C-like serine protease (3CLpro) ([@bib74]).

Protein S is a glycoprotein expressed on the surface of viruses, and it plays key roles in the internalization of the virus and attachment to the host cell. It has a molecular weight of about 200 kDa ([@bib60]). The attachment of the virus to the host cell is essentially ensured by the dominance of RDB links and the HR regions ([@bib96]). It consists of two subunits: the subunit S1 which ensures the fusion with the host cell at the amino-terminal and the subunit S2 which ensures the fusion at the carboxyl-terminal ([@bib96]).

The S1 subunit (including the N-terminal domain and the RBD) and S2 (encoding fusion peptides and conserved HR). RBD is characterized by two core and extern subdomains, the latter of which is less conserved and involved in the binding of CoVs with their receptors ([@bib89]).

Recently, Lu et al. (2016) showed a deletion mutation of 530 nucleotides in the S2 subunit, but the RDB region is highly conserved. Other studies have also revealed that the S gene has developed several mutations that can negatively influence the therapeutic strategies of protein targeting S.

Spicules S bind to MERS-CoV with DPP4, which is a proteolytic enzyme dipeptidyl peptidase 4, they are intrinsic glycoproteins and assigned exopeptidases ([@bib69]), which cleave dipeptides at the N-terminus end of a peptide as they have immune and vital roles for cells to cite: the interaction with CD26 ([@bib61]).

Infectious Bronchitis Virus {#s0065}
===========================

The IBV, a member of Coronaviridae ([@bib9]), is a highly pathogenic respiratory agent responsible for infectious bronchitis that is a major disease in the poultry field and may be associated fertility, nephritis, and respiratory problems as well as effects on the production of hatched eggs. ([@bib9]) Like all Coronaviridae, it has a single-strand linear positive-sense RNA genome. Although the structural similarity of Coronaviridae is round, IBV has a diameter of 100--160 nm and long petal-shaped spikes (spicules S) on the surface of the virus ([@bib32]). Characterized by S, E, M, and N proteins, it differs in accessory proteins and genome size ([Figure 7.2](#f0015){ref-type="fig"}, [Figure 7.4](#f0025){ref-type="fig"}). IBVs are counted as prototypes of Coronaviridae ([@bib10]).

The first replications of the virus are at the level of tracheal epithelial cells. Viral infection with IBV causes several pathological mucosal changes, including ciliary loss, degeneration and necrosis of epithelial cells, glandular degeneration, inflammatory cell infiltration, and epithelial hyperplasia ([@bib55]). According to [@bib9], IBV serotypes that share more than 95% amino acid identity in S1 should have cross protection, while IBV strains share less than 85% amino acid identity but do not protect each other ([@bib9]) ([Fig. 7.10](#f0065){ref-type="fig"} ).Figure 7.10Coloration immunofluorescente de la section de paraffine rénale du rein 5 jours après la fièvre avec Egypte/Beni-Suef/01 ([@bib2]). La fluorescence intracytoplasmique dans la touffe glomérulaire et la doublure endothéliale des vaisseaux sanguins rénaux dans les zones inter tubulaires (40×).

Although a large number of IBV strains and variants have been described in the recent years ([@bib20]), most studies have been limited to the classification and differentiation of IBV strains in genotyping, pathotyping, protections, and serotypes, with a remarkable lack of studies dealing with the specific immunity components and mechanisms involved in the pathogenesis of this virus: this would allow us to understand the depth and the system semantic epidemic virus. At the level of virus replication, they are similar to all CoVs.

Specific receptors are still poorly known, but α-2, 3-linked sialic acid has been shown to be essential for attachment of spicules ([@bib1], [@bib58]). In addition to the replicase gene, the final 5′ and 3′ UTR sequences, with certain specific secondary structures, are required for replication of the genomic RNA. Nucleocapsid (N) is also needed for efficient synthesis of viral RNA ([@bib81], [@bib101]).

Isolation and Diagnostic of Infectious Bronchitis Virus {#s0070}
-------------------------------------------------------

### Isolation of Infectious Bronchitis Virus From Eggs {#s0075}

Specific pathogen-free embryonated chicken eggs are recommended for primary isolation of IBV. Treated samples (10%--20% w/v) in phosphate buffered saline are used for egg inoculation, after being clarified by low-speed centrifugation and filtration through bacteriological filters. A volume of 100--200 μL of the treated sample are inoculated into the allantoic cavity of 9--11 day embryos ([@bib21]). Embryo mortality in the first 24 hours is considered nonspecific death. The allantoic fluids of the inoculated eggs (36--48 hours postinoculation) are harvested and pooled ([@bib16], [@bib17]). Blind passage to another set of eggs for up to three to four passes is made.

The last passage is left for 7 days to detect the presence of pathognomonic embryonic changes: stunted embryos and wound with feather dystrophy and urate deposits in the mesonephros. These lesions could also appear at the second pass ([@bib21]). The embryo-adapted strains induce greater embryo mortality. Isolation of IBV should be confirmed by serum neutralization or reverse transcription polymerase chain reaction (PCR).

### Tracheal Culture {#s0080}

Tracheal cycle culture (0.5--1.0 mm thick) of 19- to 20-day embryos can be used for primary isolation of IBV directly from field samples [@bib14]). The rings are maintained in *N*-2-hydroxyethylpiperazine-*N*′-2-ethanesulfonic acid Eagle's medium in roller drums (15 revolutions/h) ([@bib54]). Ciliostasis within 24--48 hours is an indication for virus multiplication; however, other viruses could produce similar lesions so further identification of the virus is needed.

The diagnosis of infectious diseases is made by the direct and/or indirect detection of infectious agents. By direct methods, the particles of the agents and/or their components, such as nucleic acids, structural or nonstructural proteins, enzymes, etc., are detected. Indirect methods demonstrate the presence of antibodies induced by infections.

The most common methods for direct detection are isolation or in vitro culture, electron microscopy, immunofluorescence, immunohistochemistry, enzyme immunoassays (ELISA), nucleic acid hybridization, and various nucleic acid amplification techniques such as the PCR.

The most common methods of indirect detection of infectious agents are serological tests, such as viral neutralization, ELISA, hemagglutination inhibition tests, etc.

Interspieces Viral Transmission {#s0085}
===============================

Although viruses and microorganisms have the property of host specificity due to various factors, we quote"The sensitivity of the cell to a virus via the presence of receptors allows the tropism of viruses and the presence of the factors necessary for the replication of the virus in the host cell ([@bib65]). Coronaviridae are the exception, as several viruses that are detected in humans have phylogenetic and genetic similarity to those isolated from other animal hosts ([@bib93], [@bib10]). These nonspecific properties that CoVs possess may be due to accessory CoV genes, which are already thought to play a role in host tropism and adaptation to a new host. *S*-Glycoprotein appears to be the main determinant for the success of initial events of infection between species."

Bats are home to a wide range of CoVs, including the acute respiratory syndrome (SARS-CoV) and acute respiratory syndrome virus (MERS-CoV) CoV viruses. SARS-CoV has crossed the species barrier in masked palm civets and other animals in live animal markets in China; genetic analysis suggests that this occurred at the end of 2002. Several people in the immediate vicinity of palm civets were infected with SARS-CoV. Ancestral MERS-CoV virus crossed the species barrier in camel camels; serological evidence suggests that this occurred more than 30 years ago ([@bib19]). Abundant MERS-CoV circulation in camel camels results in frequent zoonotic transmission of this virus. SARS-CoV and MERS-CoV spread among humans primarily through nosocomial transmission, resulting in the infection of healthcare workers and patients at a higher frequency than the infection of their loved ones. The transmission is done by several horizontal levels animal--animal and animal--man and man--man.
